SUMMARY Segregation analysis was performed to evaluate possible differences in mutation rates in man. It was based on 514 males with Duchenne type muscular dystrophy (DMD) from five of nineteen hospitals for muscular disease in Japan. The estimated proportion of sporadic cases (new mutations) was 0.291 0.046, which is in excellent agreement with the expected 0-333 if there is no sex difference in mutation rates. The rate of mutation was estimated to be 6.3 x 10-5 per generation. The incidence and prevalence rates among males were estimated to be 217 x 10-6 and 49*9 x 10-6, respectively. In men, spermatogenesis begins about the age of 12, whereas in women primary oocytes are already formed at birth and have begun their first reduction division. This division is completed at puberty.4 These sex differences in gametogenesis lead to differences in the predictions ofthree putative models of mutation: (1) mutation rates depend on total chronological age of parent (so there is no sex difference); (2) mutation occurs predominantly during mitosis, (so mutation rates are higher in men than in women); and (3) mutation occurs predominantly after cessation of cell division (so
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Duchenne muscular dystrophy (DMD) is a fatal hereditary disease resulting from a sex-linked gene with a high mutation rate.' Expression typically occurs only in boys, with onset usually in the first five years of life, but occasionally as late as the second decade. Female heterozygotes may occasionally have atypical dystrophic symptoms. Death occurs from inanition or respiratory infection usually in the second decade. This genetic trait is of particular interest because it offers an excellent opportunity not only to estimate the mutation rate but also to test the hypothesis of a possible sex difference in mutation rates in man. 2 3 In men, spermatogenesis begins about the age of 12, whereas in women primary oocytes are already formed at birth and have begun their first reduction division. This division is completed at puberty.4 These sex differences in gametogenesis lead to differences in the predictions ofthree putative models of mutation: (1) mutation rates depend on total chronological age of parent (so there is no sex difference); (2) mutation occurs predominantly during mitosis, (so mutation rates are higher in men than in women); and (3) mutation occurs predominantly after cessation of cell division (so *Supported by an award to the senior author from the Association of Radiation Effects under the title 'Statistical genetic analysis on the mutation rates in man ' in 1974 Three parameters are involved in valid segregation analysis: p, the segregation frequency of the disease among sibs; x, the proportion of sporadic cases; and 7r, the probability of ascertainment. The present material provides an estimate of ir from the distribution of probands among affected sibs (table 1) . We have 0-686 ±4 0'059 for data set 1 and 0 for data set 2.
The segregation frequency of fully penetrant sex-linked genes in men is expected to be p=1/2. However, it is necessary to correct for bias in estimates of p because of differential selection (such as death of DMD hemizygotes in utero) and because of delayed onset in sibs. The penetrance y may be obtained from lf(t)G(t), where f(t) is the frequency of age t at death or at last examination among normal and affected sibs or this frequency with the index cases excluded, and G(t) is the cumulative frequency of onset at age t among affected cases.9 After such correction we have p=y/2=0 460 for the ages of the men, with an average penetrance (y) of 0 911 for affected men who are not probands, 0 903 for all sibs, and 0 948 for affected men.
Taking p=0460 and 7t=0-686 for data set 1, the hypothesis of no sex difference was tested by assuming x=1/3, as expected from equation 1 if m=1 and u=v. The estimated proportion of sporadic cases in data set 1 was x =0 201 ± 0 070 and this did not differ significantly from x=0 333 (X2=(0 333-0.201)2/0.0702=3*56, df=1) (table 2).
In contrast, taking p=0-460 and it =0 in data set 2, the estimate of x, which differed significantly from 1/3, was x=0 530±0 054 (x2=l4 13, df=1).
Suspecting that ir=0 was an underestimate, the proportion of sporadic cases was re-estimated for data set 2 assuming 7t=0 686 as in data set 1 (table 3) . In this case, x=0 359 + 0-061 and does not differ significantly from 1/3. Combining the two sets of data, the hypothesis that p=0A460, x=0 333, and 7t=0 686 is compatible with the present material, giving an estimate x=0 291 ± 0 046. No significant heterogeneity between the two xs was 
where n(t) is the number in the general population at age t, G(t) is the cumulative frequency of onset at age t, and D(t) is the cumulative frequency of death at age t among affected subjects. G(t) and D(t) were obtained from the present material and n(t) has been taken from a demographic year book.'1 The ratios of P/I were 0 250 in 1960 and 0 212 in 1970. We took an average of 0-230. The prevalence A/it is then 750 ± 51,sinceA=514andit=0 686 ± 0 059.
Norikaza Yasuda and Kiyotaro Kond6
The population size N should be determined by the male population of the area served by the six hospitals studied. Since no such information is available at present, we first assumed it to be the total number of men who reside in the prefectures from where at least one proband was reported. The size of the male population was 35400279 in 1965 from 29 prefectures.11 However, only one proband was reported from two prefectures, Nara-ken and Ohsaka-fu, respectively. Ignoring these, we have N=31223 136 so that P=(24±2) x 10-6 and I=(104.3 ± 8 7) x 10-6. This is a half of the incidence currently observed.12 Owing to uncertainty about the size of the population served by all six hospitals, it seems unwise to conclude that the mutation rate of the DMD gene is lower in Japanese women than in Caucasian women.
Therefore, further evaluation was concentrated on the Chiba prefecture where the ascertainment was performed more carefully. Having A=46, i=0 686, and N=1 343 167 in 1965 for Chiba prefecture, we obtain P = (49 9±3 4) ± 10-6 and I = (217 0± 14 8) x 10-6. These figures would be underestimates, since the ascertainment probability is likely to be overestimated, presumably because of higher ascertainment among proband brothers. If we take these figures as representative of Japan, then the effective size of the male population served by the six hospitals is N= 15 011 055 or 48 e 1 % of the total male population. Since the total number of men in the whole of Japan in 1965 was 48692138, the number of affected men in Japan is estimated to be 48692138 x (49 9 ±3 4) x 10-6 = 2430±17, and the estimated mutation rate of the DMD gene in women is 0 291 x 217 x 10-6 = 6 3 x 10-5 per generation. The corresponding figure in men is (1-2 x 0@ 291) x 217-0 x 10-6= 9.1 x 10-5 as a face value.
Discussion
The estimated rate of incidence I = 217 0 x 10-6 is comparable with the figure of Morton and Chung,10 although the latter give the figure 279 x 10-6 for DMD including benign forms of X linked muscular dystrophy. Some pertinent figures by other workers can be found in Brooks and Emery,12 who obtained I = 265 x 10-6 in south-east Scotland and I = 212 x 10-6 as the crude mean of ten studies, some with clear evidence of incomplete ascertainment. All studies were of the same magnitude. Vogel and Rathenberg3 consider the figures 'surprisingly high'. The Japanese material also supports statistically the hypothesis that there is no sex difference in mutation rates. We found x = 0-291 ± 0-046 to be the proportion of sporadic cases. Davie and Emery13 reanalysed some Caucasian material and found an average of x of 0 335 ± 0-098. Morton and Chung'0 gave a comparable estimate to the present one as 0*355 ± 0* 050. Most studies, except for Morton and Chung,10 did not state the proportion of sporadic cases with proper allowance for incomplete ascertainment. A deficiency of isolated cases might be observed on the incorrect assumption of truncated selection or the probability of ascertainment being it=-1.14 In contrast, the assumption of single selection (it =0), as in the case of a part of the present data, results in an excess of sporadic cases. Therefore, proper correction of ascertainment bias is crucial before more complicated explanations of differences fromtheoretical expectationaresought. In segregation analysis, the segregation frequency p is rather robust against variation in the ascertainment probability it, whereas estimates of the proportion of sporadic cases Duchenne muscular dystrophy is unusually favourable for determining sex differences in mutation rates because the fertility of affected persons is zero. Therefore, mutation-selection equilibrium and the value of selection coefficients are not in question. Genetic drift, reproductive compensation,20 ending reproduction after the birth of an affected boy, or selective abortion of sons of carriers may disturb this equilibrium, but at present Duchenne muscular dystrophy confirms the view that there is no sex difference in the mutation rate in man.
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